Section Arrow
Quote
ARCT.NASDAQ
- Arcturus Therapeutics Holdings
Quotes are at least 15-min delayed:2026/04/15 09:41 EDT
Regular Hours
Last
 8.81
+0.13 (+1.50%)
Day High 
8.83 
Prev. Close
8.68 
1-M High
9.08 
Volume 
24.66K 
Bid
8.82
Ask
8.84
Day Low
8.715 
Open
8.75 
1-M Low
6.36 
Market Cap 
246.71M 
Currency 美元 
P/E -- 
%Yield 4.85 
10-SMA 8.26 
20-SMA 7.51 
50-SMA 7.52 
52-W High 24.17 
52-W Low 5.85 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.40/-4.24
Enterprise Value
267.50M
Balance Sheet
Book Value Per Share
7.53
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
67.22M
Operating Revenue Per Share
9.24
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
IMMPImmutep Limited0.8799+0.5651+179.51%-- 
LIMNLiminatus Pharma Inc0.196+0.0162+9.01%-- 
ALLOAllogene Therapeutics1.885-0.395-17.32%-- 
LNAILunai Bioworks Inc.0.2984-0.0404-11.92%-- 
RVMDRevolution Medicines149.035+2.025+1.38%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.